SeaCrest Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $425K | Sell |
5,431
-507
| -9% | -$40.9K | 0.05% | 329 |
|
|
2026
Q1 | $515K | Sell |
5,938
-663
| -10% | -$63.5K | 0.06% | 318 |
|
|
2025
Q4 | $659K | Sell |
6,601
-556
| -8% | -$54K | 0.07% | 259 |
|
|
2025
Q3 | $700K | Sell |
7,157
-544
| -7% | -$50K | 0.07% | 245 |
|
|
2025
Q2 | $671K | Sell |
7,701
-524
| -6% | -$44.4K | 0.07% | 247 |
|
|
2025
Q1 | $739K | Buy |
8,225
+258
| +3% | +$23.1K | 0.08% | 239 |
|
|
2024
Q4 | $636K | Buy |
7,967
+251
| +3% | +$21.7K | 0.07% | 279 |
|
|
2024
Q3 | $695K | Sell |
7,716
-5,247
| -40% | -$441K | 0.07% | 267 |
|
|
2024
Q2 | $1.02M | Buy |
12,963
+683
| +6% | +$56K | 0.12% | 173 |
|
|
2024
Q1 | $1.07M | Buy |
12,280
+3,949
| +47% | +$337K | 0.13% | 166 |
|
|
2023
Q4 | $705K | Sell |
8,331
-2,754
| -25% | -$210K | 0.09% | 238 |
|
|
2023
Q3 | $869K | Sell |
11,085
-98
| -0.9% | -$8.2K | 0.11% | 190 |
|
|
2023
Q2 | $985K | Sell |
11,183
-471
| -4% | -$40.5K | 0.12% | 168 |
|
|
2023
Q1 | $940K | Buy |
11,654
+1,354
| +13% | +$110K | 0.13% | 180 |
|
|
2022
Q4 | $800K | Sell |
10,300
-722
| -7% | -$58.5K | 0.11% | 210 |
|
|
2022
Q3 | $890K | Sell |
11,022
-775
| -7% | -$69.6K | 0.14% | 165 |
|
|
2022
Q2 | $1.06M | Sell |
11,797
-4,599
| -28% | -$466K | 0.13% | 163 |
|
|
2022
Q1 | $1.82M | Buy |
16,396
+2,922
| +22% | +$309K | 0.21% | 94 |
|
|
2021
Q4 | $1.39M | Buy |
13,474
+195
| +1% | +$22.6K | 0.15% | 133 |
|
|
2021
Q3 | $1.67M | Buy |
13,279
+489
| +4% | +$63.3K | 0.2% | 101 |
|
|
2021
Q2 | $1.59M | Buy |
12,790
+578
| +5% | +$72.6K | 0.19% | 107 |
|
|
2021
Q1 | $1.44M | Buy |
12,212
+299
| +3% | +$35K | 0.19% | 107 |
|
|
2020
Q4 | $1.4M | Sell |
11,913
-12
| -0.1% | -$1.32K | 0.2% | 109 |
|
|
2020
Q3 | $1.24M | Buy |
11,925
+320
| +3% | +$32.1K | 0.2% | 110 |
|
|
2020
Q2 | $1.06M | Buy |
11,605
+363
| +3% | +$34.8K | 0.18% | 113 |
|
|
2020
Q1 | $1.01M | Buy |
11,242
+326
| +3% | +$34.7K | 0.22% | 99 |
|
|
2019
Q4 | $1.24M | Sell |
10,916
-950
| -8% | -$104K | 0.21% | 113 |
|
|
2019
Q3 | $1.29M | Buy |
11,866
+407
| +4% | +$42.5K | 0.24% | 94 |
|
|
2019
Q2 | $1.12M | Sell |
11,459
-83
| -0.7% | -$7.58K | 0.23% | 107 |
|
|
2019
Q1 | $1.05M | Sell |
11,542
-47
| -0.4% | -$4.21K | 0.18% | 113 |
|
|
2018
Q4 | $1.05M | Sell |
11,589
-385
| -3% | -$36K | 0.22% | 95 |
|
|
2018
Q3 | $1.18M | Buy |
11,974
+424
| +4% | +$39.2K | 0.2% | 96 |
|
|
2018
Q2 | $989K | Buy |
11,550
+113
| +1% | +$9.44K | 0.18% | 111 |
|
|
2018
Q1 | $917K | Buy |
11,437
+27
| +0.2% | +$2.23K | 0.17% | 115 |
|
|
2017
Q4 | $921K | Buy |
+11,410
| New | +$914K | 0.17% | 118 |
|
Other funds holding MDT
SeaCrest Wealth Management's MDT Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Medtronic (MDT) stake by 8.5% in Q2 2026, selling an estimated $40.9K and leaving 5,431 shares worth $425K. The position accounts for 0.05% of the portfolio, ranked #329.
SeaCrest Wealth Management first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.82M in Q1 2022. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- SeaCrest Wealth Management held 5,431 shares of Medtronic worth $425K as of Q2 2026.
- SeaCrest Wealth Management sold 507 Medtronic shares in Q2 2026, an estimated $40.9K.
- Medtronic made up 0.05% of SeaCrest Wealth Management's portfolio in Q2 2026, its #329 holding.
- SeaCrest Wealth Management first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Medtronic position peaked at $1.82M in Q1 2022.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.